This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05222555
Brief Title: Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients (MINDway)

First Submitted : January 11, 2022
First Submitted that Met QC Criteria : January 24, 2022
First Posted : February 3, 2022

Last Update Submitted that Met QC Criteria : November 22, 2023
Last Update Posted : November 24, 2023